| Bioactivity | RVG (RVG29) is a peptide derived from Rabies Virus Glycoprotein that binds to the α-7 subunit of nicotinic acetylcholine receptors (AchR) of neuronal cells. RVG enhances delivery of Mycobacterium tuberculosis antigens to antigen-presenting cells[1]. |
| Name | RVG |
| CAS | 115136-25-9 |
| Sequence | Tyr-Thr-Ile-Trp-Met-Pro-Glu-Asn-Pro-Arg-Pro-Gly-Thr-Pro-Cys-Asp-Ile-Phe-Thr-Asn-Ser-Arg-Gly-Lys-Arg-Ala-Ser-Asn-Gly |
| Shortening | YTIWMPENPRPGTPCDIFTNSRGKRASNG |
| Formula | C141H217N43O43S2 |
| Molar Mass | 3266.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Omar Garnica, et al. Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide. Tuberculosis (Edinb). 2019 May:116S:S34-S41. |
RVG
CAS: 115136-25-9 F: C141H217N43O43S2 W: 3266.62
RVG (RVG29) is a peptide derived from Rabies Virus Glycoprotein that binds to the α-7 subunit of nicotinic acetylcholin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.